CN106880042A - 一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 - Google Patents
一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 Download PDFInfo
- Publication number
- CN106880042A CN106880042A CN201710034123.0A CN201710034123A CN106880042A CN 106880042 A CN106880042 A CN 106880042A CN 201710034123 A CN201710034123 A CN 201710034123A CN 106880042 A CN106880042 A CN 106880042A
- Authority
- CN
- China
- Prior art keywords
- fat
- effect
- selenium
- blood
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 57
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 30
- 230000035764 nutrition Effects 0.000 title claims abstract description 29
- 208000034657 Convalescence Diseases 0.000 title claims abstract description 17
- 239000011669 selenium Substances 0.000 claims abstract description 66
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 58
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 57
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 32
- 241000196324 Embryophyta Species 0.000 claims abstract description 27
- 240000004307 Citrus medica Species 0.000 claims abstract description 20
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 235000010355 mannitol Nutrition 0.000 claims abstract description 10
- 244000088415 Raphanus sativus Species 0.000 claims abstract 5
- 235000011649 selenium Nutrition 0.000 claims description 54
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 29
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 29
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 28
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 28
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 28
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 26
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 25
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 25
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 25
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 25
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 25
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 25
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 25
- 240000000171 Crataegus monogyna Species 0.000 claims description 25
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 25
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 25
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 25
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 24
- 235000006468 Thea sinensis Nutrition 0.000 claims description 23
- 235000013557 nattō Nutrition 0.000 claims description 23
- 235000020333 oolong tea Nutrition 0.000 claims description 23
- 235000006264 Asimina triloba Nutrition 0.000 claims description 22
- 244000075850 Avena orientalis Species 0.000 claims description 22
- 235000007319 Avena orientalis Nutrition 0.000 claims description 22
- 235000009467 Carica papaya Nutrition 0.000 claims description 22
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 22
- 244000189799 Asimina triloba Species 0.000 claims description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 19
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 19
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 19
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 19
- 235000007558 Avena sp Nutrition 0.000 claims description 18
- 240000004153 Hibiscus sabdariffa Species 0.000 claims description 18
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 17
- 240000002900 Arthrospira platensis Species 0.000 claims description 17
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims description 17
- 240000005979 Hordeum vulgare Species 0.000 claims description 17
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 17
- 235000009811 Momordica charantia Nutrition 0.000 claims description 17
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 17
- 235000018365 Momordica dioica Nutrition 0.000 claims description 17
- 229940082787 spirulina Drugs 0.000 claims description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims description 16
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 16
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 16
- 229920002752 Konjac Polymers 0.000 claims description 15
- 244000046146 Pueraria lobata Species 0.000 claims description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 14
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 240000006432 Carica papaya Species 0.000 claims description 3
- 240000001910 Momordica cochinchinensis Species 0.000 claims 3
- 241000209763 Avena sativa Species 0.000 claims 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 1
- 241000219780 Pueraria Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 88
- 210000004369 blood Anatomy 0.000 abstract description 64
- 239000008280 blood Substances 0.000 abstract description 64
- 230000006870 function Effects 0.000 abstract description 42
- 210000002784 stomach Anatomy 0.000 abstract description 29
- 210000000936 intestine Anatomy 0.000 abstract description 17
- 244000197580 Poria cocos Species 0.000 abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 15
- 230000029087 digestion Effects 0.000 abstract description 12
- 150000002632 lipids Chemical class 0.000 abstract description 12
- 210000002216 heart Anatomy 0.000 abstract description 11
- 230000033228 biological regulation Effects 0.000 abstract description 9
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 7
- 230000007774 longterm Effects 0.000 abstract description 7
- 208000026435 phlegm Diseases 0.000 abstract description 7
- 230000036407 pain Effects 0.000 abstract description 4
- 230000002980 postoperative effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 3
- 208000019790 abdominal distention Diseases 0.000 abstract description 3
- 230000004087 circulation Effects 0.000 abstract description 3
- 230000031891 intestinal absorption Effects 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 2
- 238000007796 conventional method Methods 0.000 abstract description 2
- 201000006549 dyspepsia Diseases 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 69
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 35
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 29
- 241000220259 Raphanus Species 0.000 description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 239000003814 drug Substances 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 22
- 235000000346 sugar Nutrition 0.000 description 22
- 201000010099 disease Diseases 0.000 description 20
- 239000000047 product Substances 0.000 description 17
- 235000013616 tea Nutrition 0.000 description 17
- 241000700159 Rattus Species 0.000 description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 14
- 240000001740 Momordica dioica Species 0.000 description 14
- 244000269722 Thea sinensis Species 0.000 description 14
- 229930003268 Vitamin C Natural products 0.000 description 14
- 235000012000 cholesterol Nutrition 0.000 description 14
- 239000000284 extract Substances 0.000 description 14
- 230000002265 prevention Effects 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 235000019154 vitamin C Nutrition 0.000 description 14
- 239000011718 vitamin C Substances 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 12
- 229930003231 vitamin Natural products 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- -1 methyl enol Chemical class 0.000 description 11
- 150000003722 vitamin derivatives Chemical class 0.000 description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 206010020772 Hypertension Diseases 0.000 description 9
- 230000003276 anti-hypertensive effect Effects 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 230000002218 hypoglycaemic effect Effects 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 206010010774 Constipation Diseases 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 8
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 241000209140 Triticum Species 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 230000001077 hypotensive effect Effects 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000003053 toxin Substances 0.000 description 8
- 231100000765 toxin Toxicity 0.000 description 8
- 108700012359 toxins Proteins 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 241000132012 Atractylodes Species 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 208000001953 Hypotension Diseases 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 6
- 230000003796 beauty Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 208000021822 hypotensive Diseases 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 235000005875 quercetin Nutrition 0.000 description 6
- 239000002689 soil Substances 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 229930182478 glucoside Natural products 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- HNOSJVWYGXOFRP-UNPOXIGHSA-N (5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-17-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](O)C(C)(C)O)C)CC[C@@]21C HNOSJVWYGXOFRP-UNPOXIGHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- HNOSJVWYGXOFRP-UHFFFAOYSA-N Alisol A Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(O)C(C)(C)O)C)CCC21C HNOSJVWYGXOFRP-UHFFFAOYSA-N 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 235000014552 Cassia tora Nutrition 0.000 description 4
- 244000201986 Cassia tora Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 208000034189 Sclerosis Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- QMCLOHXDDPMAMI-UHFFFAOYSA-N alisol B Natural products CC(C)C(=O)C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 QMCLOHXDDPMAMI-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 235000014106 fortified food Nutrition 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- GBJKHDVRXAVITG-UNPOXIGHSA-N Alisol B Chemical compound O([C@@H]1[C@@H](O)C[C@@H](C)C=2CC[C@]3(C)[C@@]4(C)CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@@H]4[C@@H](O)CC3=2)C1(C)C GBJKHDVRXAVITG-UNPOXIGHSA-N 0.000 description 3
- 241000256844 Apis mellifera Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 206010039921 Selenium deficiency Diseases 0.000 description 3
- 241001249696 Senna alexandrina Species 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 229930188824 alisol Natural products 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 2
- JCSJTDYCNQHPRJ-UHFFFAOYSA-N 20-hydroxyecdysone 2,3-acetonide Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(OC2C(C(O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-UHFFFAOYSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 206010010075 Coma hepatic Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 244000160089 Crataegus cuneata Species 0.000 description 2
- 235000008440 Crataegus cuneata Nutrition 0.000 description 2
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 235000005903 Dioscorea Nutrition 0.000 description 2
- 244000281702 Dioscorea villosa Species 0.000 description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 2
- 244000130270 Fagopyrum tataricum Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 241001065361 Gynostemma Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 241000366676 Justicia pectoralis Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001480037 Microsporum Species 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- DORJGGFFCMZTHW-UHFFFAOYSA-N alisol C Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC(=O)C=1C(C)CC(O)C1OC1(C)C DORJGGFFCMZTHW-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- VQKFNUFAXTZWDK-UHFFFAOYSA-N alpha-methylfuran Natural products CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 238000009412 basement excavation Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 235000018927 edible plant Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 201000001059 hepatic coma Diseases 0.000 description 2
- 208000007386 hepatic encephalopathy Diseases 0.000 description 2
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001543 purgative effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 2
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 2
- ABKNGTPZXRUSOI-UHFFFAOYSA-N xylotriose Natural products OCC(OC1OCC(OC2OCC(O)C(O)C2O)C(O)C1O)C(O)C(O)C=O ABKNGTPZXRUSOI-UHFFFAOYSA-N 0.000 description 2
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 1
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- BZFBDUQOBQHBSZ-DLCQERRASA-N (3s,8r,9s,10r,13s,14s,17s)-17-[3-(dimethylamino)propyl-methylamino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol;dihydrochloride Chemical compound Cl.Cl.C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](N(C)CCCN(C)C)[C@@]1(C)CC2 BZFBDUQOBQHBSZ-DLCQERRASA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 235000013291 Alisma plantago aquatica Nutrition 0.000 description 1
- 240000004615 Alisma plantago-aquatica Species 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000011274 Benincasa cerifera Nutrition 0.000 description 1
- 244000036905 Benincasa cerifera Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 235000000318 Bindesalat Nutrition 0.000 description 1
- 244000106835 Bindesalat Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000209202 Bromus secalinus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 235000001938 Citrus medica Nutrition 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000218033 Hibiscus Species 0.000 description 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 240000006859 Jasminum officinale Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 241001446187 Kermes Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 241001299895 Microsporum ferrugineum Species 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- JCTYWRARKVGOBK-CQSZACIVSA-N Remerin Chemical compound C12=C3C4=CC=CC=C4C[C@H]1N(C)CCC2=CC1=C3OCO1 JCTYWRARKVGOBK-CQSZACIVSA-N 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- JCTYWRARKVGOBK-UHFFFAOYSA-N Roemerine Natural products C12=C3C4=CC=CC=C4CC1N(C)CCC2=CC1=C3OCO1 JCTYWRARKVGOBK-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000015761 Rumex acetosella Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- XYUNNDAEUQFHGV-UHFFFAOYSA-N [Se].[Se] Chemical compound [Se].[Se] XYUNNDAEUQFHGV-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 210000002821 alveolar epithelial cell Anatomy 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- CAMXVZOXBADHNJ-UHFFFAOYSA-N ammonium nitrite Chemical compound [NH4+].[O-]N=O CAMXVZOXBADHNJ-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002416 angiotensin derivative Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229930185803 charantin Natural products 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 229940052810 complex b Drugs 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- MGRRGKWPEVFJSH-UHFFFAOYSA-N dianthrone Natural products C12=CC=CC=C2C(=O)C2=CC=CC=C2C1=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MGRRGKWPEVFJSH-UHFFFAOYSA-N 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 230000010159 dioecy Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 208000010227 enterocolitis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 125000004387 flavanoid group Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000007983 food acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229930186669 gynosaponin Natural products 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000019680 high-energy food Nutrition 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 108091005714 interoceptors Proteins 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- CXORMDKZEUMQHX-UHFFFAOYSA-N kermesic acid Chemical compound O=C1C2=C(O)C(O)=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C CXORMDKZEUMQHX-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 231100000783 metal toxicity Toxicity 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229940086319 nattokinase Drugs 0.000 description 1
- 108010073682 nattokinase Proteins 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 1
- 229960001999 phentolamine Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000008104 plant cellulose Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000021148 salty food Nutrition 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,以富硒植物蛋白粉为主要营养成分,加入多种降血脂、降胆固醇和减肥常用的中草药,并在此基础上加入莱菔子、茯苓、玉米花粉和香橼,其中莱菔子具有消食除胀,降气化痰的作用,有利于调节手术后的肠胃功能;茯苓除了调节肠胃功能的作用外,还具有健脾,宁心的功能;玉米花粉可以调节肠胃菌群;香橼主治胃腹胀痛,消化不良,气逆呕吐,同样是起到调节手术后的肠胃功能的作用;以上几种原料有协同作用,一起使用效果比单一使用好很多;加入低聚甘露糖有助于肠道吸收,对肠道吸收功能不好的中老年人群效果显著。本发明按常规方法制成粉剂长期服用,易于吸收。
Description
技术领域
本发明涉及食品加工技术领域,特别地,涉及一种适用于肥胖、减脂手术患者恢复期的全营养配方食品。
背景技术
富硒食品就是富含微量元素硒的食品,一般分为天然富硒食品(又称植物活性硒食品),外源硒富硒食品(也称人工有机硒食品),比如黑山药、黑芝麻,黑豆,黑花生,黑米、大蒜等黑色食物都含有硒元素。
硒是人体必需的微量元素。硒参与合成人体内多种含硒酶和含硒蛋白。其中谷胱甘肽过氧化物酶,在生物体内催化氢过氧化物或脂质过氧化物转变为水或各种醇类,消除自由基对生物膜的攻击,保护生物膜免受氧化损伤;硒参与构成碘化甲状腺胺酸脱碘酶。国内市场上打着富硒旗号的食品有很多,但是每款产品的硒含量并没有明确的标注,这对消费者造成了很大的困扰,我到底要吃多少这样的食品,才能达到补硒的效果。
硒能提高人体免疫,促进淋巴细胞的增殖及抗体和免疫球蛋白的合成。硒对结肠癌、皮肤癌、肝癌、乳腺癌等多种癌症具有明显的抑制和防护的作用,其在机体内的中间代谢产物甲基烯醇具有较强的抗癌活性。硒与维生素E、大蒜素、亚油酸、锗、锌等营养素具有协同抗氧化的功效,增加抗氧化活性。同时,硒具有减轻和缓解重金属毒性的作用。
硒与它的同族元素硫相比,在地壳中的含量少得多。硒成单质存在的矿是极难找到的,全球唯一硒独立成矿的地区位于中国湖北恩施。
硒是从燃烧黄铁矿以制取硫酸的铅室中发现的,是贝齐里乌斯发现铈、钍后1817年发现的又一个化学元素。他命名这种新元素为selenium。他还发现到硒的同素异形体。他还原硒的氧化物,得到橙色无定形硒;缓慢冷却熔融的硒,得到灰色晶体硒;在空气中让硒化物自然分解,得到黑色晶体硒。
食物硒含量受地理影响很大,土壤硒的不同造成各地食品中硒含量的极大差异。土壤含硒量在0.4毫克/千克以上,就属于富硒土壤。我国72%的国土都属贫硒或缺硒土壤,长期摄入严重缺硒食品,必然会造成硒缺乏疾病。
中国营养学会对我国13个省市做过一项调查表明,成人日平均硒摄入量为26-32微克,离中国营养学会推荐的最低限度50微克相距甚远。一般植物性食品含硒量比较低,因此,开发经济、方便,适合长期食用的富硒食品已经势在必行。
发明内容
本发明目的在于提供一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,以解决技术问题。
一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下成分:荷叶、大麦苗、莱菔子、绞股蓝、番泻叶、泽泻、魔芋、决明子、山楂、伏苓、玉米花粉、木瓜、玫瑰茄、山药、乌龙茶、葛根、香橼、菊花、燕麦、纳豆、荞麦、苦瓜、螺旋藻、富硒植物蛋白粉、低聚甘露糖。
优选的,所述的适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下重量百分比的成分:荷叶0.5-1%、大麦苗1-1.5%、莱菔子0.5-1%、绞股蓝0.1-0.6%、番泻叶0.2-0.8%、泽泻1-2%、魔芋1-2%、决明子2-3%、山楂0.2-0.5%、伏苓1-2%、玉米花粉0.5-1%、木瓜1-2%、玫瑰茄0.2-0.5%、山药2-3%、乌龙茶0.2-0.5%、葛根0.3-0.8%、香橼2-3%、菊花1-2%、燕麦0.5-1%、纳豆0.3-0.8%、荞麦0.5-1%、苦瓜0.3-1%、螺旋藻1-3%、富硒植物蛋白粉50-70%和低聚甘露糖余量。
优选的,所述的适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下重量百分比的成分:荷叶0.7%、大麦苗1.1%、莱菔子0.8%、绞股蓝0.2%、番泻叶0.3%、泽泻1.2%、魔芋1.5%、决明子2.5%、山楂0.3%、伏苓1.5%、玉米花粉0.7%、木瓜1.5%、玫瑰茄0.3%、山药2.5%、乌龙茶0.3%、葛根0.5%、香橼2.5%、菊花1.5%、燕麦0.8%、纳豆0.5%、荞麦0.6%、苦瓜0.8%、螺旋藻1.2%、富硒植物蛋白粉62.5%和低聚甘露糖余量。
优选的,所述的富硒植物蛋白粉的硒含量是35-60mg/kg。
本发明的富硒植物蛋白粉,可以为富硒水稻蛋白粉、富硒小麦蛋白粉、富硒蔬菜蛋白粉或者富硒水果蛋白粉。
荷叶:含有莲碱(Roemerine)、原荷叶碱(Pronuciferine)和荷叶碱(Nuciferine)等多种生物碱及维生素C、多糖。有清热解毒、凉血、止血的作用。荷叶色青绿,气芬芳,是传统药膳中常选用的原料。荷叶有清暑利湿、升发清阳、凉血止血等功效。近代研究证实,荷叶有良好的降血脂、降胆固醇和减肥的作用,其食疗范围进一步扩大。
功效:清毒排毒:饮用前期,开始健康调节肠道,排出因过多的食物造成的毒素堆积,改善脸部色素沉着,焕发红润水嫩好气色。
降压降脂:荷叶清热解暑,升发脾阳,可平稳血压,防治高血压、高血脂等疾病;同时脂肪持续代谢出体外,消耗加快,脂肪燃烧速度增加一倍,快速消除小腹赘肉,瘦出小蛮腰。
调养泻火:荷叶碱具有清心火、平肝火、泻脾火、降肺火以及清热养神的功效,调解内分泌,改善人体微循环。
抑脂反油:荷叶碱改善油腻饮食习惯,其具有较强的油脂排斥功效,荷叶碱长期积存人体,抑制脂肪吸收,会产生潜信号惯化大脑饮食神经,从而让你对荤腥油腻的食物渐渐产生反感。
一瘦永逸:瘦人体质逐渐形成,杜绝脂肪再生,窈窕迷人曲线凸显,实现减肥成功,持久不反弹。
解脂:魔鬼身材荷叶片所含荷叶碱,以国际工艺提取,生理性提纯达9成以上,浓度是目前市面同类产品中偏高的。其中含有多种有效的化脂生物碱,能有效分解体内的脂肪,并且强劲排出体外。
疏通排毒:荷叶碱能密布人体肠壁上,形成一层脂肪隔离膜,阻止脂肪吸收,防止脂肪堆积。有效打通人体各类代谢通路,清除自由基,调解脏腑功能。
调养保健:中医学认为,荷叶性味苦涩,平,归肝、脾、胃、心经。有清暑利湿、升发清阳、凉血止血等功效。而且还具有抗有丝分裂的作用,有较强的抑菌效果。多饮亦有保健效果。
大麦苗,为禾本科植物大麦的幼苗。光滑无毛,直立,叶鞘松弛抱茎。两侧有较大的叶耳;叶舌膜质,叶片扁平。穗状花序长3-8cm(芒除外),颖线状披针形,微具短柔毛。大麦苗中所含的维生素、矿物质及蛋白质是人类与动物的必需营养。有如下功效:
1、增强体质,优化机体功能大麦苗粉是″碱性食品之王″,含有大量的维生素C、β-胡萝卜素和抗氧化酵素,长期食用可改善酸性体质,净化血液、促进新陈代谢,具有增强肌体抗感染、抗菌、镇痛等作用,长期食用可碱化血液及尿液,增加尿酸排泄,从而有效地降低痛风发作。其中所含钾、镁、钙等矿物质可起到舒缓压力,脱离亚健康状态,推迟或改善更年期的作用。
2、排毒养颜,延缓衰老大麦苗粉中SOD酶使胃肠道有益菌群大量繁殖,口臭和体臭会自然消失。大麦嫩苗粉末的吸附能力,将人体代谢产生的氨、氛及黄曲霉素、亚硝酸氨和多环芳烃等致癌物质吸附后排出,从而改善面部暗疮、青春痘、皮肤粗糙、缺乏弹性、色素沉积等现象。其大量抗氧化酵素和膳食纤维的排毒作用可以保肝、护肝、预防肝炎。同时使得肠道内的代谢产物体积增大、松软、密度降低,促进肠道蠕动,改善了大便干结、便秘等问题。
3、调控血糖,减肥瘦身能限制部分糖和脂肪的吸收,并使体内脂肪消耗增加,有效控制肥胖,防止动脉硬化,使血压稳定,对糖尿病、心脑血管疾病有良好改善作用。
4、均衡营养以低温干燥法制成的大麦苗粉比其它食品含有更丰富的矿物质、维他命。如:钾含量同比香蕉多出25倍,钙比牛奶多出10倍,铁比菠菜多出5倍,镁比小麦面粉多出6倍,及于其它食物找不到的微量元素锌。而维他命方面,维他命B1比蕃茄多出16倍,维他命B2比生菜多出45倍,维他命C比橙多出7倍,维他命E比小麦面粉多出20倍。其它营养素如叶酸比菠菜多出8倍。
莱菔子别名:萝卜子、萝白子、菜头子。夏季果实成熟时采割植株,晒干,搓出种子,除去杂质,再晒干。功能主治:消食除胀,降气化痰。用于饮食停滞、脘腹胀痛、大便秘结、积滞泻痢、痰壅喘咳。入脾、胃、肺经,能消食除胀,功效显著,有“冲墙倒壁”之称。临床习用于治疗实(食、湿、积滞)证。然而,本品并非仅仅是消食除胀,对虚证用之,获效亦佳,因其性和平,其气味又不峻,无偏胜之弊,不可囿于“冲墙倒壁”之说,有破气之嫌(实则是平气之有余),而弃之不用。
1、对胃肠运动的作用实验表明:莱菔子生品,和经炒、炙的炮制品能使离体兔肠的收缩幅度增高,但对离体兔肠的紧张性无明显影响;三种制品均能对抗肾上腺素对肠管的抑制作用.莱菔子生品能使豚鼠胃肌条紧张性降低,炒莱菔子和炙莱菔子则使其紧张性先升高后降低.三种制品均能使胃肌条的收缩幅度增高;使胃幽门部环行肌紧张性和收缩幅度增高.炒莱菔子对小鼠小肠有明显的推进作用;三种制剂对小鼠胃排空均有抑制作用.
2、抗病原微生物作用莱菔子水浸剂(1∶3)在试管内对同心性毛癣菌、许兰黄癣菌、奥杜盎小芽胞癣菌、铁锈色小芽胞癣菌、羊毛状小芽胞癣菌、星形奴卡菌等皮肤真菌均有不同程度的抑制作用.莱菔子含抗菌物质,其有效成分为莱菔素.对葡萄球菌和大肠杆菌有显著抑制作用;亦能抑制链球菌、化脓球菌、肺炎球菌、大肠杆菌等生长.莱菔素对病毒亦有抑制作用,以DNA病毒较RNA病毒为敏感.
3、降压作用莱菔子水-醇提取液给猫和犬静脉注射,有非常明显的降压作用;浸膏给兔灌胃和肾型高血压大鼠灌胃,亦有显著的降压作用.有报告认为,莱菔子的降压作用与交感神经无关,大量阿托品或切断两侧迷走神经不能阻断莱菔子的降压作用,其降压机制与M-胆碱反应关系不大;普鲁卡因可减弱莱菔子的降压幅度,提示血管内感受器可能与莱菔子的药理作用有关.实验证明:莱菔子对肠管平滑肌有松弛作用,并增加狗肢体血流量,说明其有扩张血管作用;椎动脉给药对兔、猫有降压作用.因此可以认为该药除对血管的直接扩张作用而引起降压外,并能部分地通过中枢神经系统发挥其降压作用.亦有实验表明:莱菔子注射液对兔急性缺氧性肺动脉高压和体动脉压有明显降低作用;增大莱菔子剂量,可使其降肺、体动脉压强度加大,与酚妥拉明相比,莱菔子能明显延长降压时间.
4、其他作用大鼠长期饲喂莱菔子提取物,能干扰其甲状腺素的合成.莱菔子水提取液给大鼠腹腔注射,对巴豆油性肉芽肿的炎性增生有明显抑制作用,但抗渗作用较弱.由莱菔子中分离提出的β-谷甾醇有一定的镇咳、祛痰作用,为莱菔子治疗气管炎提供了理论根据;该成分尚能治疗人体血清胆固醇升高、防止冠状动脉粥样硬化,提示在治疗冠心病方面也可能有一定作用.
绞股蓝:喜阴湿温和的气候,多野生在林下、小溪边等荫蔽处,多年生攀援草本。在中国主要分布在陕西平利、甘肃康县、湖南、湖北,云南、广西等省,号称“南方人参”,生长在南方的绞股蓝药用含量比较高,民间称其为神奇的“不老长寿药草”。
保健作用
1、健肠胃增进消化吸收:服绞股蓝后,肠胃蠕动加快,食欲增加耐饥渴的时间长,既治便秘又治便溏。
2、补脑安神:对大脑皮层兴奋和抑制的反应能保持适当的绞股蓝平衡,对中枢神经有双向调节作用。具有优良的镇痛、安眠、抗紧张的功效。
3、护心保脉:在降低心肌壁紧张、缓和脑血管及外周血管阻力的基础上,能增强心脑活力,加大冠状动脉流量,缓和动脉硬化,促使整体循环更加旺盛而流畅。
4、调脂减肥:实验证明,不忌食肥腻而服绞股蓝组,与忌肉不服绞股蓝组,定期检查比较,体内胆固与中性脂肪含量相近。由此可见绞股蓝对人体内脂肪有良性转化调节作用。
5、健身强力:服绞股蓝与不服的老鼠比较,其游泳时间约长31-57%,而体力恢复也快得多,人服绞股蓝后,体力精力更加充沛,不易疲劳,即使疲倦了也易于恢复,从而工作效率大增。
6、抗过敏:人体某部分机能虚弱,会对某些物质产生过敏,而形成支气管喘息、皮肤丘疹、关节疼痛等症,绞股蓝对这些病效果颇佳。
7、抗癌:药理实验证明,绞股蓝既有防止正常细胞癌变,又有促使癌细胞逐渐恢复正常的功效,患鼠服绞股蓝组与不服组相比,癌瘤减轻44.8%,存活期延长53.3%。
8、抗衰美容:通过人体细胞培养试验表明:人的皮肤细胞和胎和肺细胞的再生次数为22代和51代,而在培养其中添加提取的绞股蓝皂甙,则可分别延长到27代和55代。由此证实绞股蓝有参与细胞复活的显著作用。常饮绞股蓝的人能加强血液循环,促进新陈代谢有规律地进行,从而保持和恢复皮肤的健美。”
番泻叶,异名旃那叶、泻叶、泡竹叶来源为豆科植物狭叶番泻或尖叶番泻的小叶。英文名FOLIUM SENNAE,为刺激性泻药,通过肠粘膜和神经从刺激肠蠕动,属于猛药,建议尽量少用。作用于结肠,一般几个小时内生效。
抗菌作用番泻叶浸液对多种细菌有抑制作用,如大肠杆菌、变形杆菌、痢疾杆菌、甲型链球菌以及白色念珠和某些致病性皮肤真菌。
泽泻(学名:Alisma plantago-aquatica Linn.),多年生水生或沼生草本。块茎直径1-3.5厘米,或更大。花药长约1毫米,椭圆形,黄色,或淡绿色;瘦果椭圆形,或近矩圆形,种子紫褐色,具凸起。产黑龙江、吉林等省区。生于湖泊、河湾、溪流、水塘的浅水带,沼泽、沟渠及低洼湿地亦有生长。花较大,花期较长,可用于花卉观赏。亦可入药,主治肾炎水肿、肾盂肾炎、肠炎泄泻、小便不利等症。
药理作用
1、降血脂作用
泽泻的脂溶性部份对实验性高胆固醇血症家兔有明显的降胆固醇作用和抗动脉粥样硬化作用,由其中分离得的泽泻醇A、B及泽泻醇A、B、C的乙酸酯,除泽泻醇B外,都有显着的降胆固醇作用。以0.1%的含量加入实验性高脂血症大鼠的饲料中,可使血胆固醇下降50%以上,其中以泽泻醇A-24-乙酸酯作用最强。泽泻的乙醇提取物、乙醇浸膏的乙酸乙酯提取物等,对实验性高胆固醇血症家兔和大鼠都有降血脂作用。乙酸乙酯提取物和其不溶于醋酸一水中的残留部分作用最强。醋酸乙酯提取物每日口服1g/kg,对饲以普通饲料的正常大鼠亦有明显的降胆固醇作用。用同位表标记法证明,泽泻醇A有抑制小鼠小肠酯化胆固醇的能力,并可使胆固醇在大鼠小肠内的吸收率降低34%,但不影响亚油酸的吸收。
2、对肝脏的保护作用
泽泻醇A乙酸酯、泽泻醇B乙酸酯和泽泻醇C乙酸酯可保护因四氯化碳中毒的小鼠肝脏,其中以泽泻醇C乙酸酯效果最好。
3、对心血管系统的作用
泽泻浸膏给犬和家兔静脉注射,有轻度降压作用,并持续约30分钟左右。泽泻摩醇对各种实验动物有轻度降压作用,其降压作用并不明显影响血浆肾素和ACE活性或醛固酮水平。泽泻醇提物在体外对肾上腺素引起的兔离体主动脉条件收缩有缓慢的松弛作用。泽泻摩醇可抑制由血管紧张素引起的家兔主动脉条的收缩,其收缩作用具有剂量依赖性。泽泻摩醇用离体心脏灌流技术可见减少心输出量和心率以及左心室压力,但可增加冠脉流量。
4、利尿作用
用盐水负载的小鼠或大鼠做利尿实验,小鼠皮下注射泽泻醇A乙酸酯100mg/kg能增加尿液中K+的分泌量,但口服同样剂量则无效。大鼠口服泽泻醇A乙酸酯或泽泻醇B30mg/kg剂量时,明显增加Na+的分泌量,与对照组比较P<0.05和P<0.01。
5、降血糖作用
泽泻有轻度降血糖作用。
6、对免疫功能的影响
其水煎剂可降低细胞免疫功能。
魔芋:生长在疏林下,是有益的碱性食品,对食用动物性酸性食品过多的人,搭配吃魔芋,可以达到食品酸、碱平衡。此外,魔芋还具有水平降血糖、降血脂、降压、散毒、养颜、通脉、1、排毒:其丰富的植物纤维素,帮助活跃肠道功能,加快排泄体内有害毒素,预防和减少肠道系统疾病病变发生率。
2、减肥:热量极低,在充分满足人们的饮食快感的同时不会增肥,无须刻意节食,便能达到均衡饮食从而理想减肥效果。(中国体育界和香港各界人士对此点十分推崇。
3、通便:所含丰富的葡萄甘露聚糖,有效刺激肠壁,保持肠道清爽,防治痔效果立竿见影,(在日本有″肠道清道夫或铁扫耙″之美誉)。
4、洁胃:大量可溶性植物纤维促进胃肠蠕动,可减少有害物质在胃肠、胆襄中的滞留时间,有效地保护胃粘膜,清洁胃壁。
5、疾病防治:天然甘露聚糖被医学界充分论证可抑制胆固醇、降血脂、降血糖、扩张血管、预防动脉硬化等心脑血管系统疾病,颇具延年益寿功效。
6、防糖尿病:魔芋中的植物纤维被医学证明有增加血液中胰岛素,降低血糖,对控制、预防和治疗糖尿病有极好的辅助效果。
7、平衡盐份:魔芋具有调节或平衡体内盐份之功效。(营养学证明,人体每天摄取盐份应维持在10g以下)。
8、补钙:100克魔芋天然食品中含钙约43毫克,更重要的是其所含之钙成份极易溶解被人体吸收,此富钙佳品亦当属补钙首选。
决明子:是“决明”的种子,为常用中药,种子入药,具有清肝明目、通便的功能。主治高血压、头痛、眩晕、急性结膜炎、角膜溃疡、青光眼、痈疖疮疡等症。用其叶泡茶,中老年人长期饮用,可使血压正常,大便通畅。决明在植物群落里生命力极其旺盛,常常与其他植物争夺营养,因此在北美洲等地区,决明被视为一种难以根除的野草。
决明子又称“还瞳子”,决明子含有多种维生素和丰富的氨基酸、脂肪、碳水化合物等,近年来其保健功能日益受到人们的重视。决明子具有清肝火、祛风湿、益肾明目等功能,常饮决明子茶,可使血压正常,大便通畅,老眼不花。临床实验证明,喝决明子茶可以清肝明目、防止视力模糊、降血压、降血脂、减少胆固醇等,对于防治冠心病、高血压都有不错的疗效;而且决明子富含维生素A及锌,可防治夜盲症以及避免小儿缺锌。此外,决明子茶润肠通便的功能也能解决现代人肠胃及便秘的问题,可以治疗大便燥结,帮助顺利排便。决明子茶的泡法十分简单,只要用15~20克决明子用热开水冲泡即可,也可依个人喜好放入适量的糖,当茶饮用,每日数次,若能配上枸杞子及菊花,效果更佳。
1、抗菌作用:决明子醇提取物对葡萄球菌、白喉杆菌、伤决明子寒杆菌、副伤寒杆菌、大肠杆菌均有抑制作用,而水提取物则无效。
2、抗真菌:水浸剂用试管稀释法,1∶20对奥杜盎小孢子菌,1∶10对许兰黄癣菌及石膏样小孢子菌均有抑制作用。
3、降压:水浸剂和乙醇浸液对麻醉狗、猫、兔均有降压作用。
4、降血脂:决明子煎剂或决明子散剂6g/只喂饲大鼠8周,对实验性高血脂症大鼠能降低血浆胆甾醇、甘油三酯,并降低肝中甘油三酯的含量。
5、抗血小板聚集:决明子煎剂或散剂6g/kg喂饲大鼠8周,对ADP诱导的大鼠血小板聚集有抑制作用。
6、对免疫功能的影响决明子水煎醇沉剂15g/kg皮下注射可使小鼠胸腺萎缩,外周血淋巴细胞ANAE染色阴性率明显降低,使2,4-二硝基氯苯(DNCB)所致小鼠皮肤迟发型超敏反应受抑,但对血清溶血素形成无明显影响,另外决明子水煎醇沉剂可使小鼠腹腔巨噬细胞吞噬鸡红细胞百分率和吞噬指数明显增高,溶菌酶水平也明显高于对照组。
7、保肝作用决明子热水提取物口服670mg/kg对四氯化碳中毒小鼠肝脏有弱的解毒作用。决明子经石油醚脱脂、氯仿提取,再用甲醇提取,结果该甲醇提取物有显著的护肝作用。进一步从中分得大黄酚-1-O-三葡萄糖甙、大黄酚-1-O-四葡萄糖甙在1mg/ml时对四氯化碳损伤的肝细胞有弱的保护作用,还发现芦荟大黄素也有类似的抗肝毒作用。
8、泻下作用决明子具有缓泻作用。其流浸膏口服后泻下作用在3-5h达到高峰。从水煎液中得50%乙醇可溶部分,依次用醋酸乙酯、丁酸,分别得到各可溶部分及水溶部分。将泻下活性最高的丁醇部分用葡聚糖凝胶柱分离出数个组分,将具有活性的组分用酸水解,得到相同的大黄酚、二蒽酮及d-葡萄糖。口服这些组分后,可从大肠内检测到亚硝基二苯胺的缩合物及大黄酚蒽酮,但对用氯霉素处理而抑制肠内细菌增殖的小鼠,其泻下活性减半,蒽酮生成也降低。
山楂:可食用植物,仁果类水果,质硬,果肉薄,味微酸涩。落叶灌木。枝密生,有细刺,幼枝有柔毛。小枝紫褐色,老枝灰褐色。能防治心血管疾病。山楂是我国特有的药果兼用树种。
山楂也叫山里红、红果、胭脂果,为蔷薇科植物山里红或山楂的干燥成熟果实,质硬,果肉薄,酸甜适中,风味独特。山楂有很高的营养价值和医疗价值,老年人常吃山楂制品能增强食欲,改善睡眠,保持骨骼和血液中钙的恒定,预防动脉粥样硬化,因此山楂被视为“长寿食品”。
山楂的主要成分为黄酮类及有机酸类化合物。黄酮类化合物主要有牡荆素(vitexin)、槲皮素(quercetin)、槲皮苷(quercitin)、金丝桃苷(hyperoside)、3 7,4’,5,7一四羟基黄酮一7一葡萄糖苷(3 7,4 7,5,7一tetrahydroxy flavone一7一glucoside)和芦丁(rutoside);有机酸主要有山楂酸(maslinic acid)、柠檬酸(citric acid)、熊果酸(ur-solic acid)等。另外尚含有磷脂(phosphatide)、维生素C(vitamin C)、维生素B2(vita-min B2)等。山楂味酸性温,气血并走,化瘀而不伤新血,行滞气而不伤正气,应用于肉食积滞证,泻痢腹痛、疝气痛、瘀滞腹痛胸痛、恶露不尽、痛经、吐血、便血等。现代单用本品制剂治疗心血管疾病、细菌性痢疾等,均有较好疗效。山楂含有大量的维生素C与微量元素,能够扩张血管,降低血压,降低血糖,能够改善和促进胆固醇排泄而降低血脂,预防高血脂的发生,山楂能够开胃促进消化,山楂所含有的脂肪酶也能够促进脂肪的消化。山楂所含有的黄酮类与维生素c、胡萝卜素等物质能够阻断并减少自由基的生成,可增强机体的免疫力,延缓衰老,防癌抗癌。山楂能够活血化瘀,帮助消除瘀血状态,辅助治疗跌打损伤。山楂对子宫有收缩作用,在孕妇临产时有催生效果。山楂主要含有黄酮类、低聚黄烷类、有机酸类、微量元素,另外还有含有三萜类、甾体类和有机胺类等成分。近几年来,山楂在降血脂、降血压、抗脑血及其作用机制方面取得了重大进展。
茯苓:为百合科多年生常绿攀缘状灌木,多生于山坡或林下,分布于安徽、浙江、江西、福建、湖南、湖北、广东、广西、四川、云南等省。入药部分只选择其干燥后的根茎。常于夏、秋二季采挖,除去须根,洗净后干燥、入药;或趁鲜切成薄片后干燥、入药。甘、淡,平。归肝、胃经。具有除湿,解毒,通利关节的作用。用于湿热淋浊,带下,痈肿,瘰疬,疥癣,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛。
茯苓功效:
利尿作用
茯苓用于小便不利,水肿等症。茯苓功能利水渗湿,而药性平和,利水而不伤正气,为利水渗湿要药。凡小便不利、水湿停滞的症候,不论偏于寒湿,或偏于湿热,或属于脾虚湿聚,均可配合应用。如偏于寒湿者,可与桂枝、白术等配伍;偏于湿热者,可与猪苓、泽泻等配伍;属于脾气虚者,可与党参、黄耆、白术等配伍;属虚寒者,还可配附子、白术等同用。
利尿作用
茯苓用于小便不利,水肿等症。茯苓功能利水渗湿,而药性平和,利水而不伤正气,为利水渗湿要药。凡小便不利、水湿停滞的症候,不论偏于寒湿,或偏于湿热,或属于脾虚湿聚,均可配合应用。如偏于寒湿者,可与桂枝、白术等配伍;偏于湿热者,可与猪苓、泽泻等配伍;属于脾气虚者,可与党参、黄耆、白术等配伍;属虚寒者,还可配附子、白术等同用。
除了以上的一些作用,茯苓还可有效的改善心脏的血液循环能力,对已中老年人来说,由于年龄较大,身体难免会出现一些心脑血管疾病,而茯苓可治疗心悸,失眠等症状,除此之外又能养心安神等,所以在日常煲汤的时候可以添加一些茯苓增加营养。
玉米花粉:人们通常利用玉米的籽粒和茎叶,而对数量巨大的玉米花粉却很少注意.其实,在各种植物花粉中,玉米花粉有明显的数量优势.通过对玉米花粉的测定表明,玉米花粉中含有18种氨基酸,可被人体直接吸收的游离氨基酸含量高达23%,其蛋白质含量为22%~25%,还含有糖和有机酸等.
我国科学家研究发现,玉米花粉对食品致病菌能起到明显的抑制作用。科研人员分别将人工采集的玉米花粉和蜂玉米花粉在常温下浸提,将蜂玉米花粉在80℃水溶浸提以及将蜂玉米花粉破壁后在80℃水溶浸提。结果表明,几种浸提物均有抑制食品致病菌效果,后者抑制作用最强。这些花粉可抑制的食品致病菌有:伤寒沙门氏菌、痢疾志贺氏菌、金黄色葡萄球菌、乙型溶血性链球菌、蜡样芽孢杆菌、小肠结肠炎尔森氏菌、魏氏梭菌、肉毒梭菌等。抑制最低浓度视病菌不同而异,在2.5%-10%之间,最佳抑菌作用为pH6.0-7.0。研究结果还表明,玉米花粉抑菌还有耐高温、高压的优点。
功效:
1.玉米花粉中的维生素B6,可以控制色氨酸向成黄尿氨酸的转化,对糖尿病有预防作用;对已患者能提供足够的矿物质钾,促使脂肪和蛋白质正常代谢,亦可防止因酮体过量可能产生的中毒危险,保障糖尿病患者的生命安全。玉米花粉更有充足的活性氨基酸和酶等,可修补破损的胰脏组织,促进胰岛素分泌,减轻糖尿病症状。
2.玉米花粉中的维生素B6可控制因酪氨酸转化所引起的血管硬化,增加血管壁弹性、增强毛细血管,降低血压。
3.玉米花粉中的维生素、矿物质锌和镁,对青春痘和其它的皮肤疾病,如头发屑、化妆品过敏等都有很好的功效。维生素A可滋养毛孔,B6可以改善皮肤品质,B2可以促进饱和脂肪酸的代谢,使皮肤不再油腻,减少青春痘的发生。
木瓜:是大家熟悉的水果,不但味道又香又甜,而且还有保健、美容的功效。在木瓜里,包含各种酶元素,维生素(维他命)及矿物质,而最丰富的维生素是维生素A、复合维生素B、维生素C及维生素E。
据timesofindia的报告,如果定时食用木瓜,对身体会有一些重要的益处:
1、木瓜富有营养,低卡路里,以致对进行减肥的人大有益处;
2、木瓜有助于治皮外伤或其它外伤;
3、木瓜富有抗炎化合物,也有抗癌作用,对于患骨质疏松症、关节炎和浮肿的人,最好有规律地食用木瓜,同时能够防癌。
4、木瓜也能帮助头皮和头发的健康,木瓜的摄入量有助于头发的生长并能防止头皮屑(头垢);
5、木瓜是最有功效排毒方法之一,多吃木瓜就能排出体内的毒素;
6、对于患便秘和消化不良的病人,多吃木瓜能减轻病状。
玫瑰茄:又名洛神花、洛神葵、山茄等,是锦葵科木槿属的一年生草本植物,广布于热带和亚热带地区,原产于西非、印度,目前在我国的广东、广西、福建、云南、台湾等地均有栽培。玫瑰茄植株高1.5~2米,茎淡紫色,直立,主干多分枝。叶互生。花在夏秋间开放,花期长,花萼杯状,紫红色,花冠黄色。每当开花季节,红、绿、黄相间,十分美丽,有“植物红宝石”的美誉。\n玫瑰茄,具有清热解暑、养颜、消斑、解酒等功效。
种植在山区不受污染旷野中,因为光照充足、紫外线强烈。产品外观颗粒饱满,花瓣厚实,紫红黑亮,融水色泽艳丽清新,气微香、味酸,富含维生素C、接骨木三糖苷、柠檬酸等营养成份;玫瑰茄的花萼为肉质结构,多汁,含有丰富的蛋白质、有机酸、维生素C,多种氨基酸,大量的天然维生素和人体所需的矿物质,如铁、钙、磷等。其成份分析如下:还原糖5.7克;蛋白质2.37克;果胶19.8克;苹果酸3.3克;单宁1.09克;花青素14.5克;维生素89毫克/100克,含有人体所必需冬氨酸、谷氨酸、脯氨酸、甘氨酸、丙氨酸、赖氨酸、精氨酸等十七种氨基酸以及抗氧化功能显著的花青素、多元酚、呋喃醛、羟甲基呋喃醛,尤其高含Vc一抗坏血酸。这些成份具有平肝降火、清热消炎、生津止渴、降压减脂、醒脑安神、清除自由基等作用。其中木槿酸,被认为对治疗心脏病、高血压、动脉硬化等有一定疗效,可降低胆固醇和甘油三脂;另外的一些成份还对肠、子宫肌肉有解痉作用于,同时还有驱虫作用并能促进胆汁分泌、降低血液浓度、刺激肠壁蠕动。玫瑰茄不但有以上的医用和保建作用,而且又是一种色、香、味俱佳的食品,用其生产出的纯天然健康饮品,是一种难得的天然饮料。玫瑰茄气微香、味酸,维生素C、接骨木三糖苷、柠檬酸等营养成份,有益于调节和平衡血脂,增进钙质吸收,有益于调节和平衡血脂,增进钙质吸收,促进儿童发育,促进消化等。具有清凉解毒利水,降血压等等功效。无毒性。
山药,即薯蓣,别名怀山药、淮山药、土薯、山薯、山芋、玉延。多年生草本植物,茎蔓生,常带紫色,块根圆柱形,叶子对生,卵形或椭圆形,花乳白色,雌雄异株。块根含淀粉和蛋白质,可以吃。单子叶植物,10属650种,广布于全球的温带和热带地区,我国有薯蓣属Dioscorea 1属,约80种。原产山西平遥、介休,现分布于我国华北、西北及长江流域的江西各省区。
营养分析
1.健脾益胃、助消化:山药含有淀粉酶、多酚氧化酶等物质,有利于脾胃消化吸收功能,是一味平补脾胃的药食两用之品。不论脾阳亏或胃阴虚,皆可食用。临床上常与胃肠饮同用治脾胃虚弱、食少体倦、泄泻等病症。
2.滋肾益精:山药含有多种营养素,有强健机体,滋肾益精的作用。大凡肾亏遗精,妇女白带多、小便频数等症,皆可服之。
3.益肺止咳:山药含有皂甙、黏液质,有润滑,滋润的作用,故可益肺气,养肺阴,治疗肺虚痰嗽久咳之症。
4.降低血糖:山药含有粘液蛋白,有降低血糖的作用,可用于治疗糖尿病,是糖尿病人的食疗佳品。
5.延年益寿:山药含有大量的黏液蛋白、维生素及微量元素,能有效阻止血脂在血管壁的沉淀,预防心血疾病,取得益志安神、延年益寿的功效;
6.抗肝昏迷:近年研究发现山药具有镇静作用,可来抗肝昏迷。
乌龙茶,亦称青茶、半发酵茶,是中国几大茶类中,独具鲜明特色的茶叶品类。乌龙茶是经过杀青、萎雕、摇青、半发酵、烘焙等工序后制出的品质优异的茶类。乌龙茶由宋代贡茶龙团、凤饼演变而来,创制于1725年(清雍正年间)前后。品尝后齿颊留香,回味甘鲜。乌龙茶的药理作用,突出表现在分解脂肪、减肥健美等方面。在日本被称之为“美容茶”、“健美茶”。
中国医学研究者声明乌龙茶具有瘦身的功效。乌龙茶之所以流行,完全是因为它溶解脂肪的减肥效果,这种说法也确实有科学的根据。因为茶中的主成分一单宁酸,证实与脂肪的代谢有密切的关系,而且实验结果也证实,乌龙茶的确可以降低血液中的胆固醇含量,实在是不可多得的减肥茶。实验证明,每天喝一公升乌龙茶,有抑制胆固醇上升的效果。虽然饮用量应该依各人身体的状况决定,但是当食物太油腻时,最好也能够搭配乌龙茶,不但有饱腹感,还可以去除油腻。乌龙茶本身能够刺激胰脏脂肪分解酵素的活性,减少有关糖类和脂肪类食物的吸收,促进脂肪的燃烧,从而达到瘦身的效果,特别是能够减少腹部脂肪的堆积。同时经常喝乌龙茶得人,还具有缓解精神疲劳、消食止痢、抑制肥胖、和美容养颜等功效。
1981年,日本和洋女子大学宫川丰美和川村一男教授,就乌龙茶对动物脂肪代谢的影响进行试验,证明能显著抑制血中胆固醇及中性脂肪的增加。
1983年,福建省中医药研究所观察了一组血中胆固醇较高的病人,在停用各种降脂药物的情况下,每日上下午两次饮用乌龙茶,连续24周后,病人血中胆固醇含量有不同程度下降。进一步的动物试验表明,乌龙茶有防止和减轻血中脂质在主动脉粥样硬化作用。饮用乌龙茶还可以降低血液粘稠度,防止红细胞集聚,改善血液高凝状态,增加血液流动性,改善微循环。此外,体外血栓形成试验,也表明乌龙茶有抑制血栓形成的作用。
葛根,中药名。为豆科植物野葛的干燥根,习称野葛。秋、冬二季采挖,趁鲜切成厚片或小块;干燥。甘、辛,凉。有解肌退热,透疹,生津止渴,升阳止泻之功。常用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。
葛根供药用,葛根提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质——洗胰清糖素(cics),具有降血糖、血脂、抗炎等作用。葛根有解表退热、生津止渴、止泻的功能,并能改善高血压糖尿病病人的项强、头晕、头痛等症状。有效成分为黄豆甙元、黄甙及葛根素等。
作用功效:
1.提高肝细胞的再生能力,恢复正常肝脏机能,促进胆汁分泌,防止脂肪在肝脏堆积。
2.促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤。
3.对高血脂形成的冠状动脉硬化,通过改善心肌缺血状态,防治冠心病、心绞痛、心肌梗塞等心血管疾病。
4.对高血脂形成的脑动脉硬化,通过改善脑缺血状态,防治脑梗塞、偏瘫、血管性痴呆等脑血管疾病。
5.强化肝胆细胞自身免疫功能,抵抗病毒入侵。
6.降血糖,具有延缓衰老、调节血脂血糖、促进造血功能等方面的作用,并
香橼(学名:Citrus medica L.)又名枸橼或枸橼子,属不规则分枝的灌木或小乔木。新生嫩枝、芽及花蕾均暗紫红色。单叶,稀兼有单身复叶,叶片椭圆形或卵状椭圆形,叶缘有浅钝裂齿。总状花序有花达12朵,花瓣5片。果椭圆形、近圆形或两端狭的纺锤形,重可达2000克,果皮淡黄色,粗糙,难剥离,果肉无色,近于透明或淡乳黄色,爽脆,味酸或略甜,有香气;种子小,平滑,子叶乳白色,多或单胚。花期4-5月,果期10-11月。
药用功效
香橼所含挥发油对胃肠道有温和刺激作用,能促进肠胃里蠕动和消化液分泌,排除肠内积气,并有祛痰作用。
1.抗炎作用:
该品所含的橙皮甙对豚鼠因缺乏维生素C而致的眼睛球结膜血管内细胞凝聚及毛细血管抵抗力降低有改善作用,能降低马血细胞之凝聚。与栓塞(Thrombogenic)饲料或与致粥样硬化饲料共同喂养大鼠,均可延长大鼠存活时间。能刺激缺乏维生素C的豚鼠的生长速度,增加豚鼠肾上腺、脾及白细胞中维生素C的含量。
2.抗病毒作用:
橙皮甙加入小泡性口炎病毒前,将小鼠纤维细胞放于200μg/ml的橙皮甙中预先孵化处理,能保护细胞不受病毒侵害约24小时。预先处理Hela细胞能预防流感病毒的感染。但其抗病毒的活性可被透明质酸酶所消除。
菊花是菊科植物。菊花Chrysanthemum morifolium Ramat鳞托菊的干燥头状花序,是中国常用中药,具有疏风、清热、明目、解毒之功效。主要治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒等症。现代药理研究表明,菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性。中国药用菊花在市场上有八大主流商品来源,分别为杭菊、亳菊、贡菊、滁菊、祁菊、怀菊、济菊、黄菊,而《中国药典》I部(2000年版)根据菊花产地和加工方法的不同,收载了亳菊、滁菊、贡菊和杭菊四个品种。菊花为药食同源植物,国内外对其分类、鉴定、化学、临床、药理等方面均有报道,现仅就国内外对菊花的化学成分和药理活性研究作一概述。同时菊花茶具有抑制癌细胞,扩张冠状动脉,降低血压的作用,长期饮用还能够增加人体钙质,调节心肌功能,适合中老年人饮用,同时还能够降低胆固醇。
燕麦(拉丁学名:Avena sativa L.)为禾本科植物,《本草纲目》中称之为雀麦、野麦子。燕麦不易脱皮,所以被称为皮燕麦,是一种低糖、高营养、高能食品。燕麦性味甘平。能益脾养心、敛汗。有较高的营养价值。可用于体虚自汗、盗汗或肺结核病人。煎汤服,或″舂去皮作面蒸食及作饼食。″(《救荒本草》).燕麦耐寒,抗旱,对土壤的适应性很强,能自播繁衍。燕麦富含膳食纤维,能促进肠胃蠕动,利于排便,热量低,升糖指数低,降脂降糖,也是高档补品之一,在贫苦地区是不可缺少的干粮。
1997年美国FDA认定燕麦为功能性食物,具有降低胆固醇、平稳血糖的功效。美国《时代》杂志评选的″全球十大健康食物″中燕麦位列第五,是唯一上榜的谷类。
谷粒供磨面食用,或作饲料,营养价值很高。在中国人日常食用的小麦、稻米、玉米等9种食粮中,以燕麦的经济价值最高,其主要表现在营养、医疗保健和饲用价值均高。燕麦中的β-葡聚糖可减缓血液中葡萄糖含量的增加,预防和控制肥胖症、糖尿病及心血管疾病。燕麦富含的膳食纤维具有清理肠道垃圾的作用。燕麦片中膳食纤维丰富,可长时间保持饱腹感,防止摄入过多的油腻和咸味食物,达到减肥瘦身的效果。
燕麦的医疗价值和保健作用,已被古今中外医学界所公认。据1981~1985年中国农科院与北京市心脑血管研究中心、北京市海淀医院等18家医疗单位5轮动物试验和3轮997例临床观察研究证明,裸燕麦能预防和治疗由高血脂引发的心脑血管疾病。即服用裸燕麦片3个月(日服100克),可明显降低心血管和肝脏中的胆固醇、甘油三脂、β-脂蛋白,总有效率达87.2%,其疗效与冠心病无显著差异,且无副作用。对于因肝、肾病变,糖尿病,脂肪肝等引起的继发性高脂血症也有同样明显的疗效。长期食用燕麦片,有利于糖尿病和肥胖病的控制。
纳豆:在日本已经有一千多年的历史了,纳豆最初是利用稻草上自然的纳豆芽孢杆菌发酵,在寺庙的厨房制造,因为寺庙的厨房叫“纳所”,所以叫纳豆,纳豆当时是素食的僧侣们重要营养来源,也是日本皇室、僧侣、贵族、武士的御用营养品。
近几年来,经日本的医学家、生理学家研究得知,大豆的蛋白质具有不溶解性,而做成纳豆后,变得可溶并产生氨基酸,而且原料中不存在的各种酵素会由于纳豆菌及关联细菌产生,帮助肠胃消化吸收。纳豆的成分是:水分61.8%、粗蛋白19.26%、粗脂肪8.17%、碳水化合物6.09的%、粗纤维2.2%、灰分1.86%,作为植物性食品,粗蛋白、脂肪最丰富。纳豆系高蛋白滋养食品,纳豆中含有的醇素,食用后可排除体内部分胆固醇、分解体内酸化型脂质,使异常血压恢复正常(《身体科学》杂志1994年1月号,日本评论社出版,第4页)。
研究表明,纳豆的保健功能主要与其中的纳豆激酶、纳豆异黄酮、皂青素、维生素K2等多种功能因子有关。纳豆中富含皂青素,能改善便秘,降低血脂,预防大肠癌、降低胆固醇、软化血管、预防高血压和动脉硬化,抑制艾滋病病毒等功能;纳豆中含有游离的异黄酮类物质及多种对人体有益的酶类,如过氧化物歧化酶、过氧化氢酶、蛋白酶、淀粉酶、脂酶等,它们可清除体内致癌物质、提高记忆力、护肝美容、延缓衰老等有明显效果,并可提高食物的消化率;摄入活纳豆菌可以调节肠道菌群平衡,预防痢疾、肠炎和便秘,其效果在某些方面优于现在常用的乳酸菌微生态制剂;纳豆发酵产生的粘性物质,被覆胃肠道粘膜表面上,因而可保护胃肠,饮酒时可缓解酒醉的作用。
荞麦(学名:Fagopyrum esculentum Moench.),别名:甜荞、乌麦、三角麦等;一年生草本。茎直立,高30-90厘米,上部分枝,绿色或红色,具纵棱,无毛或于一侧沿纵棱具乳头状突起。叶三角形或卵状三角形,长2.5-7厘米,宽2-5厘米,顶端渐尖,基部心形,两面沿叶脉具乳头状突起。
荞麦是短日性作,喜凉爽湿润,不耐高温旱风,畏霜冻。荞麦在中国大部分地区都有分布,在亚洲和欧洲国家也有分布。
荞麦性甘味凉,有开胃宽肠,下气消积。治绞肠痧,肠胃积滞,慢性泄泻的功效;同时荞麦还可以做面条、饸饹、凉粉等食品。
降糖作用
首先是荞麦淀粉中直链淀粉比例较高,可影响水分子进入,延迟糊化与消化速度,从而抑制了餐后血糖的升高速度。
中国著名营养专家、协和医科大学教授杜寿玢近日指出,荞麦在粮食作物中可说是“全能冠军”。研究表明,荞麦特别是苦荞麦,其营养价值居所有粮食作物之首,并且含有其他粮食作物所缺乏的特种微量元素及药用成分,对现代“文明病”及几乎所有中老年心脑血管疾病均有预防和治疗功能。
杜寿玢教授对苦荞麦情有独钟,尽管甜荞色泽白、口感好,但是从保健角度来看,苦荞更胜一筹。此外,不少临床研究结果也不断证实,苦荞具有降血脂、降血糖、降血压、降体重和抗氧化的功能。
荞麦的医用功能很多。
首先是荞麦淀粉中直链淀粉比例较高,可影响水分子进入,延迟糊化与消化速度,从而抑制了餐后血糖的升高速度。
其次,苦荞脂肪含量明显高于小麦,其中不饱和脂肪酸占83.2%,油酸占47.1%,亚油酸占36.1%(亚油酸能降低血液胆固醇、预防动脉粥样硬化)。
第三是黄酮类物质,包括槲皮素、芦丁等(芦丁具有降低血管通透性、加强脆弱的微细血管的功能,还能促进胰岛素分泌;槲皮素是从多方面保护人体的抗氧化剂)。
第四是新近发现苦荞中含有荞麦糖醇,能调节胰岛素活性,具有降糖作用。
苦瓜气味苦、无毒、性寒,入心、肝、脾、肺经具有清暑解渴、降血压、血脂
主治中暑、暑热烦渴、暑疖、痱子过多、痢疾、疮肿、结膜炎、目赤肿痛、痈肿丹毒、烧烫伤、少尿等病症。另外,苦瓜的维生素C含量很高,具有预防坏血病、保护细胞膜、防止动脉粥样硬化、提高机体应激能力、保护心脏等作用苦瓜里面含有一种成分,可以有效抑制正常细胞的癌变和促进特变细胞的复原,具有一定的抗癌作用,而且还具备有降血脂和血压的特点。不仅如此,苦瓜还有预防骨质疏松、调节内分泌、抗氧化等作用,同时进一步提高人体抵抗力,提高身体里面的反应机制。
苦瓜提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质——洗胰清糖素(cics),具有降血糖、血脂、抗炎等作用。苦瓜的新鲜汁液,含有苦瓜甙和类似胰岛素的物质,具有良好的降血糖作用,是糖尿病患者的理想食品。
果实中含有丰富的蛋白质、糖、矿物质及各种维生素等。特别是维生素C含量尤为突出,为黄瓜的14倍,冬瓜的5倍,番茄的7倍。据分析,每100克鲜果含碳水化合物3克,蛋白质0.9克,脂肪0.2克,钙18毫克,磷29毫克,维生素C为84毫克。此外,还含有铁、维生素A、B和无机盐等。苦瓜含有的特殊糖甙,味苦性寒,能刺激唾液及胃液分泌,可促进食欲,帮助消化。此外,还具有解毒等功效,深受广大群众的喜爱。
螺旋藻(学名:Spirulina)是一类低等生物,原核生物,由单细胞或多细胞组成的丝状体,体长200-500μm,宽5-10μm,圆柱形,呈疏松或紧密的有规则的螺旋旋形弯曲,形如钟表发条,故而得名。具有减轻癌症放疗、化疗的毒副反应,提高免疫功能,降低血脂等功效。
以有效的预防心脏病和中风疾病的发作,螺旋藻里的Y-亚麻酸可以降低人体所含的胆固醇,从而可以有效降低高血压和预防心脏病减低胆固醇。
功效:螺旋藻含营养丰富,是碱性食品,能给人体补充营养又可改变酸性体质,调整新陈代谢活动。与琼珍灵芝搭配食用,可以调节血糖,对糖尿病病情的稳定有显著效果;螺旋藻内所含有的天然藻蓝蛋白,可以增强人体细胞的免疫功能,从而提高我们身体的免疫能力和抗病能力;
大部分胃病患者均属胃酸过多,导致胃炎、胃溃疡等疾病,而螺旋藻是碱性食品,螺旋藻内含有很高的植物性蛋白质以及丰富的叶绿素、β-胡萝卜素等,这些营养物质对胃酸中和及胃肠道粘膜修复、再生和正常分泌功能极为有效,特别适用于肠胃患者。
缺铁性贫血是非常普遍的一个现象,而螺旋藻含有极为丰富的铁质和叶绿素,这些营养元素可以有效改善人体贫血的状况。
本发明具有如下优点:本发明的富硒食品,以富硒植物蛋白粉为主要营养成分,加入多种降血脂、降胆固醇和减肥常用的中草药,并在此基础上加入莱菔子、茯苓、玉米花粉和香橼,其中莱菔子具有消食除胀,降气化痰的作用,有利于调节手术后的肠胃功能;茯苓除了调节肠胃功能的作用外,还具有健脾,宁心的功能;玉米花粉可以调节肠胃菌群;香橼主治胃腹胀痛,消化不良,气逆呕吐,同样是起到调节手术后的肠胃功能的作用;以上几种原料有协同作用,一起使用效果比单一使用好很多;加入低聚甘露糖有助于肠道吸收,对肠道吸收功能不好的中老年人群效果显著。本发明按常规方法制成粉剂长期服用,易于吸收。
除了上面所描述的目的、特征和优点之外,本发明还有其它的目的、特征和优点。下面将对本发明作进一步详细的说明。
具体实施方式
以下对本发明的实施例进行详细说明,但是本发明可以根据权利要求限定和覆盖的多种不同方式实施。
实施例1
一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下重量百分比的成分:荷叶0.7%、大麦苗1.1%、莱菔子0.8%、绞股蓝0.2%、番泻叶0.3%、泽泻1.2%、魔芋1.5%、决明子2.5%、山楂0.3%、伏苓1.5%、玉米花粉0.7%、木瓜1.5%、玫瑰茄0.3%、山药2.5%、乌龙茶0.3%、葛根0.5%、香橼2.5%、菊花1.5%、燕麦0.8%、纳豆0.5%、荞麦0.6%、苦瓜0.8%、螺旋藻1.2%、富硒植物蛋白粉62.5%和低聚甘露糖余量。
所述的富硒植物蛋白粉的硒含量是45mg/kg。
实施例2
一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下重量百分比的成分:荷叶1%、大麦苗1%、莱菔子1%、绞股蓝0.1%、番泻叶0.5%、泽泻1%、魔芋2%、决明子2%、山楂0.5%、伏苓1%、玉米花粉1%、木瓜1%、玫瑰茄0.5%、山药2%、乌龙茶0.5%、葛根0.3%、香橼3%、菊花1%、燕麦1%、纳豆0.3%、荞麦1%、苦瓜0.3%、螺旋藻3%、富硒植物蛋白粉50%和低聚甘露糖余量。
所述的富硒植物蛋白粉的硒含量是60mg/kg。
实施例3
一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下重量百分比的成分:荷叶0.5%、大麦苗1.5%、莱菔子0.5%、绞股蓝0.3%、番泻叶0.2%、泽泻2%、魔芋1%、决明子3%、山楂0.2%、伏苓2%、玉米花粉0.5%、木瓜2%、玫瑰茄0.2%、山药3%、乌龙茶0.2%、葛根0.8%、香橼2%、菊花2%、燕麦0.5%、纳豆0.8%、荞麦0.5%、苦瓜1%、螺旋藻1%、富硒植物蛋白粉57%和低聚甘露糖余量。
所述的富硒植物蛋白粉的硒含量是35mg/kg。
实施例4
一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,包括以下重量百分比的成分:荷叶0.5%、大麦苗1%、莱菔子0.5%、绞股蓝0.1%、番泻叶0.2%、泽泻1%、魔芋1%、决明子2%、山楂0.2%、伏苓1%、玉米花粉0.5%、木瓜1%、玫瑰茄0.2%、山药2%、乌龙茶0.2%、葛根0.3%、香橼2%、菊花1%、燕麦0.5%、纳豆0.3%、荞麦0.5%、苦瓜0.3%、螺旋藻1%、富硒植物蛋白粉70%和低聚甘露糖余量。
对比实施例1
将实施例1中的莱菔子、玉米花粉和香橼均替换为富硒植物蛋白粉,其余配方和制备条件不变。
对比实施例2
将实施例1中的茯苓替换为富硒植物蛋白粉,其余配方和制备条件不变。
以下对实施例1-4和对比实施例1-2制作的适用于肥胖、减脂手术患者恢复期的全营养配方食品进行临床效果实验。
实验1
实验征集到减脂手术恢复期的志愿者共计300人,年龄从20-60周岁,男女不限,每个实施例有50人参加实验。
实验方法:每组志愿者服用实施例1-4和对比实施例1-2制备的全营养配方食品粉剂,每日3次,每次20g,服用方法:三餐半小时后100ml温开水冲调服用,实验期间不服用任何药物,控制饮食品种和饮食量,60天以后统计疗效。
有效:志愿者体重降低或者无明显上升;无效:志愿者体重增加。
实验结果见表1:
表1:配方食品对志愿者的辅助治疗结果
| 有效 | 无效 | 总有效率% | |
| 实施例1 | 49 | 1 | 98 |
| 实施例2 | 48 | 2 | 96 |
| 实施例3 | 48 | 2 | 96 |
| 实施例4 | 47 | 3 | 94 |
| 对比实施例1 | 42 | 8 | 84 |
| 对比实施例2 | 38 | 12 | 76 |
由以上测试结果可以知道,本发明的适用于肥胖、减脂手术患者恢复期的全营养配方食品中不加入莱菔子、玉米花粉和香橼或者不加入茯苓对部分志愿者的治疗效果有显著影响。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (4)
1.一种适用于肥胖、减脂手术患者恢复期的全营养配方食品,其特征在于,包括以下成分:荷叶、大麦苗、莱菔子、绞股蓝、番泻叶、泽泻、魔芋、决明子、山楂、伏苓、玉米花粉、木瓜、玫瑰茄、山药、乌龙茶、葛根、香橼、菊花、燕麦、纳豆、荞麦、苦瓜、螺旋藻、富硒植物蛋白粉、低聚甘露糖。
2.如权利要求1所述的适用于肥胖、减脂手术患者恢复期的全营养配方食品,其特征在于,包括以下重量百分比的成分:荷叶0.5-1%、大麦苗1-1.5%、莱菔子0.5-1%、绞股蓝0.1-0.6%、番泻叶0.2-0.8%、泽泻1-2%、魔芋1-2%、决明子2-3%、山楂0.2-0.5%、伏苓1-2%、玉米花粉0.5-1%、木瓜1-2%、玫瑰茄0.2-0.5%、山药2-3%、乌龙茶0.2-0.5%、葛根0.3-0.8%、香橼2-3%、菊花1-2%、燕麦0.5-1%、纳豆0.3-0.8%、荞麦0.5-1%、苦瓜0.3-1%、螺旋藻1-3%、富硒植物蛋白粉50-70%和低聚甘露糖余量。
3.如权利要求2所述的适用于肥胖、减脂手术患者恢复期的全营养配方食品,其特征在于,包括以下重量百分比的成分:荷叶0.7%、大麦苗1.1%、莱菔子0.8%、绞股蓝0.2%、番泻叶0.3%、泽泻1.2%、魔芋1.5%、决明子2.5%、山楂0.3%、伏苓1.5%、玉米花粉0.7%、木瓜1.5%、玫瑰茄0.3%、山药2.5%、乌龙茶0.3%、葛根0.5%、香橼2.5%、菊花1.5%、燕麦0.8%、纳豆0.5%、荞麦0.6%、苦瓜0.8%、螺旋藻1.2%、富硒植物蛋白粉62.5%和低聚甘露糖余量。
4.如权利要求1所述的适用于肥胖、减脂手术患者恢复期的全营养配方食品,其特征在于,所述的富硒植物蛋白粉的硒含量是35-60mg/kg。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710034123.0A CN106880042A (zh) | 2017-01-18 | 2017-01-18 | 一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710034123.0A CN106880042A (zh) | 2017-01-18 | 2017-01-18 | 一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106880042A true CN106880042A (zh) | 2017-06-23 |
Family
ID=59175823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710034123.0A Pending CN106880042A (zh) | 2017-01-18 | 2017-01-18 | 一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106880042A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108272078A (zh) * | 2018-01-31 | 2018-07-13 | 刘小辉 | 控制体重的特殊医学用途配方食品代餐粉及其制备方法 |
| CN108420071A (zh) * | 2018-03-29 | 2018-08-21 | 山东省食品发酵工业研究设计院 | 一种适用于代谢综合征人群的功能性食品及其制备方法 |
| CN113545479A (zh) * | 2021-07-22 | 2021-10-26 | 陕西巨子生物技术有限公司 | 一种配方食品及其应用 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066965A (zh) * | 1991-05-23 | 1992-12-16 | 安大永 | 减肥免疫晶制造方法 |
| CN1155998A (zh) * | 1996-01-31 | 1997-08-06 | 于庆安 | 一种全营养减肥套餐 |
| CN1669480A (zh) * | 2004-03-15 | 2005-09-21 | 张大康 | 低热量均衡营养蛋白质粉减肥食品 |
| CN101247735A (zh) * | 2005-08-26 | 2008-08-20 | 雀巢技术公司 | 用于肥胖患者的营养 |
| CN101669644A (zh) * | 2009-09-25 | 2010-03-17 | 杨林伟 | 一种富硒功能食品的制备方法 |
| CN104187709A (zh) * | 2014-07-26 | 2014-12-10 | 胡安然 | 肥胖、减脂手术全营养配方食品 |
-
2017
- 2017-01-18 CN CN201710034123.0A patent/CN106880042A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066965A (zh) * | 1991-05-23 | 1992-12-16 | 安大永 | 减肥免疫晶制造方法 |
| CN1155998A (zh) * | 1996-01-31 | 1997-08-06 | 于庆安 | 一种全营养减肥套餐 |
| CN1669480A (zh) * | 2004-03-15 | 2005-09-21 | 张大康 | 低热量均衡营养蛋白质粉减肥食品 |
| CN101247735A (zh) * | 2005-08-26 | 2008-08-20 | 雀巢技术公司 | 用于肥胖患者的营养 |
| CN101669644A (zh) * | 2009-09-25 | 2010-03-17 | 杨林伟 | 一种富硒功能食品的制备方法 |
| CN104187709A (zh) * | 2014-07-26 | 2014-12-10 | 胡安然 | 肥胖、减脂手术全营养配方食品 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108272078A (zh) * | 2018-01-31 | 2018-07-13 | 刘小辉 | 控制体重的特殊医学用途配方食品代餐粉及其制备方法 |
| CN108420071A (zh) * | 2018-03-29 | 2018-08-21 | 山东省食品发酵工业研究设计院 | 一种适用于代谢综合征人群的功能性食品及其制备方法 |
| CN108420071B (zh) * | 2018-03-29 | 2023-02-03 | 山东省食品发酵工业研究设计院 | 一种适用于代谢综合征人群的功能性食品及其制备方法 |
| CN113545479A (zh) * | 2021-07-22 | 2021-10-26 | 陕西巨子生物技术有限公司 | 一种配方食品及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Meireles et al. | A review of properties, nutritional and pharmaceutical applications of Moringa oleifera: integrative approach on conventional and traditional Asian medicine | |
| CN103340334B (zh) | 一种淡水鱼饲料及其制备方法 | |
| CN103416534B (zh) | 一种富硒养胃茶及其生产方法 | |
| KR20130047778A (ko) | 약용 꽃을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물 | |
| CN103039745A (zh) | 一种产蛋麻鸭的日粮精饲料及其制备方法 | |
| CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
| CN102805274A (zh) | 一种0-14日龄小麦型肉小鸭配合饲料及其制备方法 | |
| CN106617062A (zh) | 一种祛除人体湿气的富硒全营养配方食品 | |
| CN107648454A (zh) | 一种补肾膏滋及其制备方法 | |
| CN103719497A (zh) | 一种绞股蓝降脂减肥保健茶及其制备方法 | |
| KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
| CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
| JP2016077283A (ja) | 農産物と穀物菌糸体とが混合され、発酵された抗癌、抗糖尿、免疫増進用の発酵禅食組成物及びその製造方法{Fermentedfoodcompositioncomprisingagriculturalproductsandmyceliummixtureforpreventingortratingcancer、diabeticsandimprovingimmunefunction、andpreparationmethodthereof} | |
| KR20180089696A (ko) | 천연식물 추출물의 잔류농약 제거방법 | |
| Shahrajabian et al. | Exploring the quality of foods from ancient China based on traditional Chinese medicine | |
| CN106880042A (zh) | 一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 | |
| CN107692220A (zh) | 增强人体免疫力的保健药膳食品及制备方法 | |
| CN105533233A (zh) | 一种防治家禽寄生虫病的中药饲料配方 | |
| CN107156829A (zh) | 一种适用于肝病患者的全营养配方食品 | |
| CN106912921A (zh) | 一种糖尿病全营养配方食品 | |
| CN106805235A (zh) | 一种适用于呼吸系统疾病患者的全营养配方食品 | |
| CN106701410A (zh) | 健胃益气保健酒及其生产方法 | |
| CN105961684A (zh) | 健脾养胃保健茶及其生产方法 | |
| CN105361149A (zh) | 一种青稞虫草糁子营养粉及其制备方法 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170623 |